FDA has raised regulatory and safety concerns regarding certain BPC-157-related bulk substances used in compounding contexts, and the dietary supplement classification of BPC-157 products has been a topic of industry discussion through 2025 and into 2026
Studies in both normal healing and delayed healing models have shown improvements in callus volume, mineralization, bone mineral content, rate of successful union, and mechanical strength at fracture sites
For women with Polycystic Ovary Syndrome, the metabolic mechanisms of tirzepatide are particularly relevant, as insulin resistance and appetite dysregulation are central features of the condition
Together, they create a more balanced, sculpted, and defined transformation
If fatigue is a concern during treatment, our tirzepatide fatigue guide addresses this common side effect
At Elko Replenish Med Spa, PT-141 is offered to both men and women, and it is FDA-approved for women